Eton Pharmaceuticals Inc. ETON
$32.48
▼ -1.62% 24H
About
Eton Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development and commercialization of treatments for rare diseases, with particular focus on pediatric endocrinology and metabolic disorders. The company maintains a growing portfolio of FDA-approved commercial products including Increlex for s…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees44
TickerETON
Statistics
Market Cap$888.5M
Revenue (TTM)$80.0M
Net Income-$4.6M
Net Margin-5.8%
EPS—
P/E124.00
P/S9.95
P/B28.23
EV/EBITDA79.11
ROE-5.4%
Dividend Yield—
Price$32.48
Data: Twelve Data · Revenue = mcap / P/S